Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000944809-16-000025
Filing Date
2016-08-08
Accepted
2016-08-08 17:05:35
Documents
82
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q opk-6302016x10q.htm 10-Q 1439019
2 EXHIBIT 10.2 opk-6302016xex102.htm EX-10.2 335409
3 EXHIBIT 31.1 opk-6302016xex311.htm EX-31.1 11877
4 EXHIBIT 31.2 opk-6302016xex312.htm EX-31.2 11887
5 EXHIBIT 32.1 opk-6302016xex321.htm EX-32.1 4427
6 EXHIBIT 32.2 opk-6302016xex322.htm EX-32.2 4672
  Complete submission text file 0000944809-16-000025.txt   10686154

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT opk-20160630.xml EX-101.INS 2318747
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT opk-20160630.xsd EX-101.SCH 68526
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT opk-20160630_cal.xml EX-101.CAL 112737
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT opk-20160630_def.xml EX-101.DEF 541549
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT opk-20160630_lab.xml EX-101.LAB 1001154
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT opk-20160630_pre.xml EX-101.PRE 657486
Mailing Address 4400 BISCAYNE BLVD. MIAMI FL 33137
Business Address 4400 BISCAYNE BLVD. MIAMI FL 33137 305-575-4138
Opko Health, Inc. (Filer) CIK: 0000944809 (see all company filings)

EIN.: 752402409 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33528 | Film No.: 161815038
SIC: 2834 Pharmaceutical Preparations